ACE Inhibitors and ARBs To Protect Your Heart? A Guide for Patients Being Treated for Stable Coronary Heart Disease

Similar documents
Lisinopril 20 converting to losartan

Medicare Shared Savings Program Accountable Care Organization (ACO) Measures Deep Dive Series

Cardiac Medications At A Glance

Clinical Policy: ACEI and ARB Duplicate Therapy Reference Number: CP.PMN.61 Effective Date: Last Review Date: 05.18

Instructions and Checklist for Your Heart Procedure

Medications for Type 2 Diabetes CDE Exam Preparation. Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy

Annual Review of Antihypertensives - Fiscal Year 2009

Medications for Type 2 Diabetes CDE Exam Preparation

Losartan lisinopril equivalent dose

Adapted d from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 18, 2017

4/3/2014 OBJECTIVES BLOOD PRESSURE BASICS. Discuss the new blood pressure guidelines (JNC 8) and recognize the changes from JNC 7

Living with Congestive Heart Failure: A Guide to a Healthy Heart

Lisinopril to losartan equivalent

Losartan lisinopril equivalent dose 新着 news 2018 年 3 月 6 日高等部 3 年生 大阪リゾート & スポーツ専門学校に合格! 2018 年 3 月 2 日茨木市立山手台小学校との交流.

Session 35: Text Analytics: You Need More than NLP. Eric Just Senior Vice President Health Catalyst

Clinical Teach-Back Cards

Merrimack Valley Cardiology Associates. Heart Failure Education

Conversion of losartan to lisinopril

Guidelines for the Prescribing of Sacubitril / Valsartan

Lisinopril losartan conversion dose

Medications. Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy.

Heart Disease and Prevention PRESENTED BY: DOTTIE CRAIG NP- C, JANE ARCHER NP-C, KATHY DAPPER RN, NICCI FRAVEL RN

CARDIAC IMAGING QUESTIONNAIRE

Clinical Teach-Back Cards

Trandolapril to lisinopril

Drum Up Support. Living with Heart Failure. Doctor. Phone number. Emergency number. Target weight

Information in these slides is used with permission from St. Mary s Cardiac Rehab

CONCORD INTERNAL & PULMONARY MEDICINE CONGESTIVE HEART FAILURE PROTOCOL. Douglas G. Kelling, Jr., MD & C. Gismondi-Eagan, MD, FACP

LONG TERM CARE MEDICATIONS MANAGEMENT INITIATIVE JULY Prepared by the Long-Term Care Medications Management Working Group

Scientific conclusions and detailed explanation of the scientific grounds for the differences from the PRAC recommendation

Clinical Policy: Angiotesin II Receptor Blockers and Renin Inhibitors Reference Number: CP.HNMC.15 Effective Date: Last Review Date: 08.

Module 1: Evidence-based Education for Health Care Professionals

Top 200 Section 4. Cardiovascular Drugs

Treatment Options for GERD or Acid Reflux Disease A Review of the Research for Adults

Get Healthy Stay Healthy

9/13/2017. Presented by UIC College of Nursing Jessy Thomas FNP, MSN, MPH. Introduction Background Management

Entresto (Sacubitril Valsartan) An information guide

Module 1: Evidence-based Education for Health Care Professionals

8/19/2016. No Conflicts. I struggled with everything cardiac in nursing school.

Scientific conclusions and detailed explanation of the scientific grounds for the differences from the PRAC recommendation

CARDIAC REHABILITATION PROGRAMME:- MEDICATION

Antihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

The Kidney and Lupus REVISED BY THE LUPUS ONTARIO SUPPORT AND EDUCATION COMMITTEE LUPUS ONTARIO 1

State of the art treatment of hypertension: established and new drugs. Prof. M. Burnier Service of Nephrology and Hypertension Lausanne, Switzerland

PassAssured's Pharmacy Technician Training Systems. Medication Review. Cardiovascular Drugs. Pharmacy Technician Training Systems Passassured, LLC

Don t let the pressure get to you:

Alternative to lisinopril due to cough

HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP

Hypertension in Primary Care: Blood Pressure Goals for Adults Aged 60 and Older

Drug Use Criteria: Angiotensin-Converting Enzyme Inhibitors

Hypertension is also an important risk factor in the development of chronic kidney disease and heart failure.

Entresto. Summary of the Risk Management Plan (RMP) for Entresto (sacubitril/valsartan)

ASEBP and ARTA TARP Drugs and Reference Price by Categories

Coronary Artery Disease

Amlodipine/olmesartan (Azor ) is indicated for the treatment of hypertension, alone or in combination with other antihypertensive medications.

Heart Disease. Signs and Symptoms

Living Better with Heart Failure Caring for your heart

VA/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care (2008) PROVIDER REFERENCE CARDS Chronic Kidney Disease

2:15 3 pm Harold DeMonaco, Director, Innovation Support Center at Massachusetts General Hospital. News Media and New Treatments

This information explains heart failure, including causes and signs of heart failure, how heart failure is diagnosed, and how it s treated.

Hypertension, Hyperlipidemia and Obesity. Mi-CCSI

12.5mg, 25mg, 50mg. 25mg, 50mg. 250mg, 500mg, 250mg/5ml. 2.5mg, 5mg, 10mg. 5mg, 10mg, 20mg, 100mg. 25mg

Don t let the pressure get to you:

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

Managing Gout A Review of the Research for Adults

LIVING WELL WITH HEART FAILURE EDUCATION AND DISCHARGE INFORMATION

Guideline-Directed Medical Therapy

PASSPORT TO HEART HEALTH

Managing Hypertension in Diabetes Sean Stewart, PharmD, BCPS, BCACP, CLS Internal Medicine Park Nicollet Clinic St Louis Park.

Quality Data on Core Measures

This information explains the advice about the care and treatment of people with stable angina that is set out in NICE clinical guideline 126.

Dr Narender Goel MD (Internal Medicine and Nephrology) Financial Disclosure: None, Conflict of Interest: None

Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series

Physician/Clinic Collaborative Practice Agreement

MEDICATION FACT SHEET

LIVING WITH HEART FAILURE

Treatments for Open-Angle Glaucoma. A Review of the Research for Adults

Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011)

THE HEART FAILURE MANUAL: Education, Management and Improvement

Inclusion criteria Cautionary inclusion Exclusion criteria 1. Diagnosis of ischemic stroke causing measurable neurological deficit.

CHAPTER 2. Knowing YOUR MEDICATIONS. Image: istock.com/bakibg. Knowing Your Medications 23

Class Update: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Blockers (ARBs), and Direct Renin Inhibitors (DRIs)

Steps Against Recurrent Stroke (STARS)

Entresto Development of sacubitril/valsartan (LCZ696) for the treatment of heart failure with reduced ejection fraction

ANTIHYPERTENSIVES. Assoc. Prof. Bilgen Başgut

Florida Blue QUALITY PERFORMANCE METRIC STANDARDS FEBRUARY 2013

Caring for your heart during and after Chronic Myeloid Leukemia (CML) treatment

Diabetes and a Healthy Heart. Meeting 6. Welcome! Glucose. Balance Makes a Difference! Medicine Helps with. Glucose. Balance!

ACP Brief Fall 2006 prioritization. Angiotensin II Receptor Blockers (ARBs) for Proteinuria, Hypertension (HTN) and Congestive Heart Failure (CHF)

Evaluation and Management of Acute Decompensated Heart Failure (HF) with Reduced Ejection Fraction Systolic Heart Failure (HFrEF)(EF<40%

ACE inhibitors vs ARBs: Is one class better for heart failure?

Eliquis and plavix combination therapy

Advanced Heart Failure Palliative Considerations DEBBY GREENLAW, ACNPC, ACHPN, CCRN INDEPENDENT CONSULTANT ACUTE CARE NURSE PRACTITIONER

12.5mg, 25mg, 50mg. 25mg, 50mg. 2.5mg, 5mg, 10mg. 5mg, 10mg, 20mg, 100mg. 25mg. -- $2.81 Acetazolamide (IR, 125mg, 250mg, 500mg (ER)

Gestational Diabetes. A Guide for Pregnant Women

MEDICATION GUIDE Prasugrel (pra-su-grel) tablets Read this Medication Guide before you start taking prasugrel and each time you get a refill.

South Carolina Department of Health and Human Services Post Office Box 8206 Columbia, South Carolina

Information for you, your family and carers

Drug Class Review on Angiotensin Converting Enzyme Inhibitors

HEART DISEASE HEART CONDITIONS, RISKS AND PROTECTION

Transcription:

ACE Inhibitors and ARBs To Protect Your Heart? A Guide for Patients Being Treated for Stable Coronary Heart Disease

Is This Guide Right for Me? This Guide Is for You If: You have coronary heart disease, a disease affecting the arteries of your heart. You may have had a heart attack or suffer from chest pains with exercise, but your symptoms are not changing. Your coronary heart disease is in stable condition. This means that your symptoms have not changed or become worse. Your doctor recommends adding a medicine called an ACE Inhibitor or an ARB. You do not take medicine for high blood pressure (also called hypertension ). This Guide Will Not Help You If: You are making decisions about the other medicines that you may be taking for your coronary heart disease. This guide was created by reviewing the many research studies done on this topic. The information is provided here to help you make a decision about your choices based on the available evidence.

Understanding Your Disease What Is Coronary Heart Disease? This picture shows what your coronary heart disease may look like. The arteries that bring blood to your heart muscle have become narrowed or blocked. When that happens, it is hard for blood and oxygen to get to your heart. When the vessel is blocked, you may feel chest discomfort (such as pain, pressure, or tightness) when you do any physical effort or exercise. Doctors call this chest discomfort angina. What Are the Possible Problems? People with coronary heart disease are at risk for serious problems, including: Heart attack Heart failure Stroke Each of these problems can cause death or can take a long time for recovery and keep you from working or doing other activities. 1

Understanding Treatment for Coronary Heart Disease How Can I Protect Myself From Possible Problems? Although there is no cure for coronary heart disease, some medicines can help protect you from heart attack, heart failure, or stroke. Your doctor may ask you to take one or several medicines, such as: Low-dose aspirin or drugs that keep platelets in the blood from sticking together. Medicines to lower your cholesterol level. Medicines that help reduce heart rate and blood pressure, such as beta-blockers. Medicines to prevent your blood from clotting, such as warfarin. Other medicines for high blood pressure or diabetes. What About ACE Inhibitors and ARBs? Two other medicines ACE Inhibitors and ARBs have been studied to see if they can also help people with stable coronary heart disease from developing other problems. Both of these medicines lower your blood pressure and have been used to treat heart failure. ACE Inhibitors. Your doctor may also call these medicines angiotensin-converting enzyme inhibitors or ACEIs. ARBs. Your doctor may also call these medicines angiotensin II receptor blockers. 2

Understanding Your Choices You and your doctor can decide whether you should add an ACE Inhibitor or an ARB to your other medicines by: understanding and comparing the benefits of the medicine, and deciding if the benefits outweigh the possible side effects from the medicine. Is an ACE Inhibitor Right for Me? You and your doctor might want to add an ACE Inhibitor to your other medicines for coronary disease because: Doctors know more about the benefits and side effects of ACE Inhibitors than ARBs. Most people who take ACE Inhibitors experience only minor side effects. What Are the Benefits of Adding an ACE Inhibitor? There are four possible benefits to patients who add an ACE Inhibitor to their other medicines for coronary disease: It reduces your risk of dying from a heart attack or heart failure. It reduces your risk of having a nonfatal heart attack. It reduces your risk of being hospitalized because of heart failure. It reduces your risk of needing surgery or other procedures to increase blood flow to your heart muscle. This is called revascularization (pronounced ree-vask-you-lar-iz-a-shun). 3

How Much Benefit Can I Expect? The two charts below compare the results over a 4-year period for 100 people who did and did not add an ACE Inhibitor to their other medicines. Without an ACE Inhibitor, what can I expect? For every 100 people taking other medicines for coronary disease without an ACE Inhibitor, 92 people will not die from a heart attack or heart failure over 4 years ( ); 8 will die from these causes ( ). With an ACE Inhibitor, what can I expect? For every 100 people who add an ACE Inhibitor to their other medicines for coronary disease, 93 will not die from a heart attack or heart failure over 4 years ( ); 7 will die from these causes ( ). That means that 1 additional person out of every 100 people ( ) will avoid dying of a heart attack or heart failure by adding an ACE Inhibitor to their other coronary disease medicines over 4 years. The amount of benefit is about the same for avoiding a heart attack, being hospitalized with heart failure, or needing surgery or another procedure to increase blood flow to your heart muscle. 4

What are the possible side effects? Some people who take an ACE Inhibitor have these problems: A cough. Sudden fainting. Too much potassium in their blood. This may cause problems with the heart beat or the heart s rhythm. These problems are not common. Some people who take an ACE Inhibitor and then have surgery to open a blocked blood vessel have more risk of: Another surgery to open up a different blocked blood vessel. Low blood pressure. WARNING: Some studies have found that ACE Inhibitors can cause a sudden swelling of the tongue, lips, throat, hands or feet. This is called angioedema (pronounced an-gee-o-uh-dee-mah). Call your doctor right away if this happens. ACE Inhibitors can also cause serious birth defects. If you are or think you may become pregnant and are taking an ACE Inhibitor, tell your doctor and ask what you should do. 5

Should I Add an ARB? You may be someone who does experience one or more of the side effects from an ACE Inhibitor. In that case, you and your doctor may decide to add an ARB to your other medicines instead. What are the benefits of adding an ARB? Studies show that patients who add an ARB to their other medicines (because they cannot take an ACE Inhibitor) have a lower risk of either dying from a heart-related cause or having a nonfatal heart attack or stroke. What are the possible side effects? Some people who take ARBs can get too much potassium in their blood. This may cause problems with the heart beat or the heart s rhythm. These problems appear to not be common. ARBs can cause angioedema and birth defects as well. Do I need an ACE Inhibitor and an ARB? A research study has shown that taking both of these medicines does not help you any more than taking only an ACE Inhibitor. Adding both medicines can also cause more serious side effects, including: Fainting. Low blood pressure. Kidney problems. 6

Deciding What Is Best for You Which ACE Inhibitor or ARB Is Best for Me? There are many ACE Inhibitor and ARB medicines. These medicines are made by different companies. There are no major chemical differences among the ACE Inhibitor medicines or among the ARB medicines, but dose amounts and costs will vary. What Is the Cost? The amount you will have to pay will depend on: Whether you are taking a generic or a brand-name medicine. The amount of medicine that you are taking. The amount of your copay through your insurance plan. Most ACE Inhibitors and some ARBs come in a generic form. Generic medicines usually cost less than brand-name medicines. Ask your doctor to help you choose a medicine that is most effective for you and best fits your budget. Common Generic and Brand Names for ACE Inhibitors and ARBs ACE Inhibitors benazepril (Lotensin) captopril (Capoten) enalapril (Vasotec) fosinopril (Monopril) lisinopril (Prinivil, Zestril) perindopril (Aceon) quinapril (Accupril) ramipril (Altace) trandolapril (Mavik) Angiotensin II Receptor Blockers (ARBs) candesartan (Atacand) eprosartan (Tevetan) irbesartan (Avapro) losartan (Cozaar) olmesartan (Benicar) telmisartan (Micardis) valsartan (Diovan) 7

Your Doctor Can Help You Decide Ask your doctor: 1. Will an ACE Inhibitor or an ARB reduce my risk of death, heart attack, or stroke? 2. Do the possible harms or side effects from taking these medicines outweigh the benefits for me? 3. Do I need to have an operation to open up the vessels around my heart? How does this change any decisions we might make about the use of these two medicines? 4. Will an ACE Inhibitor or an ARB interact with the other medicines I m taking? Other questions you want to ask your doctor: Write the answers to your questions here: 8

Record Your Medicines Use this chart to record the names of your medicines, the amounts, and when you take them. Medicine Record Name of medicine How much I take When I take it Other Ways To Help Reduce Your Risk of Heart Problems You can lower your risk of heart attack, heart failure, or a stroke, if you: Lose weight. Exercise regularly. Eat foods that are low in fat and cholesterol. Do not smoke. Ask your doctor to help you set your goals and get started making these changes. MedLine Plus, a U.S. Government Web site, has many resources to help you. The Web site is located at: www.nlm.nih.gov/medlineplus/heartdiseasesprevention.html 9

Sources The information in this guide comes from the report Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease. It was produced by the University of Connecticut /Hartford Hospital Evidence-based Practice Center through funding by the Agency for Healthcare and Research Quality (AHRQ). For a copy of the report, or for more information about AHRQ and the Effective Health Care Program, go to www.effectivehealthcare.ahrq.gov. Additional information came from the Medline Plus Web site, a service of the U.S. National Library of Medicine and the National Institutes of Health. This site is available at www.nlm.nih.gov/medlineplus. Additional information came from a 2007 report titled Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension, AHRQ Pub. No. 08-EHC003-EF, November 2007. This summary guide was prepared by the John M. Eisenberg Center for Clinical Decisions and Communications Science at Baylor College of Medicine, Houston, Texas. AHRQ Pub. No. 10-EHC002-A May 2010